All News

The $20 million, five-year-initiative will work to increase equity in U.S. cancer care.

Jones is credited with improving diversity at the organization.

The report details the company's efforts environmental, social, and governance areas.

The new office will give clients access to the company's services in the Chinese market.

Hogan Lovells released a survey that tracked the thinking of compliance professionals who are implementing ESG into compliance programs.

Companies headquartered in the state raised the fourth highest annual total in the first half of this year.

Costs related to health care and prescription drugs are impacting large employers.

Howard University College of Pharmacy will now offer a two-year post-professional Doctorate in Pharmacy fellowship program.

Podcast recognized for its excellence in apps and podcasts category.

Industry leaders discuss new technologies, research, and investment strategies.

Amidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.

A roadmap for cohering patient perspectives.

Industry must continue research and development to combat the pandemic.

Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

New accelerator will develop products and solutions with the use of digital, data, and AI.

Investments setting up sector for future success that could one day rival its US counterpart.

Approval of Medicare and Medicaid coverage for digital therapeutics represents next step in advancing care for mental health patients.

Experienced physician with in-depth expertise in clinical development and immuno-oncology.

New senior executive brings 25 years of HR leadership and pharma industry experience.

Rise in demand for sustainable practices forces industry to be more proactive.

Role drift and clinical trials among many areas for compliance professionals to keep an eye on in 2022.

New data emerges from release of IQVIA's U.S. Medicines Trends 2022 Report.

Looking to the past reminds industry of great strides taken in clinical research for patients.

Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.

How early stage can help set you up for big stage.

Collaboration reinforces value of connecting proprietary and third-party data.

Continued push for latest technology in biopharma will advance collection of patient data.